Table 2.
the clinical characteristics of patients with or without RASI treatment.
| Rasi (n = 14) |
Non-Rasi (n = 13) |
Difference (95% CI) |
p values | |
|---|---|---|---|---|
| Sex, male | 8 (57.1) | 6 (46.2) | 51.9 (34.0, 69.3) | 1.000 |
| Age, range (yrs) | 61.4 ± 13.7 | 61.3 ± 13.8 | 0.0 (−10.8, 10.9) | 0.993 |
| Mean arterial pressure (mmHg)* | 101.7 ± 9.5 | 101.1 ± 9.9 | −3.8 (−23.3, 15.7) | 0.641 |
| Cough | 6 (42.9) | 3 (23.1) | 33.3 (18.6, 52.2) | 0.673 |
| Phlegm | 5 (35.7) | 3 (23.1) | 29.6 (15.9, 48.5) | 0.673 |
| Fever | 10 (71.4) | 9 (69.2) | 70.4 (51.5, 84.2) | 1.000 |
| length of stay (d) | 19.2 ± 6.1 | 16.9 ± 7.9 | 2.4 (−3.3, 8.1) | 0.398 |
| Time from onset to admission (d) | 6.4 ± 5.2 | 6.5 ± 5.3 | −0.0 (−4.2, 4.2) | 0.987 |
| WBC (×109/L) | 4.83 ± 1.35 | 4.85 ± 2.65 | −0.02 (−1.67, 1.63) | 0.979 |
| Lymphocyte (×109/L) | 1.19 ± 0.25 | 1.07 ± 0.44 | 0.12 (−0.17, 0.41) | 0.381 |
| Liver dysfunction | 7 (50.0) | 7 (53.8) | 51.9 (34.0, 69.3) | 0.842 |
| Cr (mmol/L) | 71.6 ± 13.9 | 81.9 ± 37.9 | −10.3 (−32.6, 12.0) | 0.350 |
| CRP (mg/L) | 17.5 ± 19.2 | 29.4 ± 31.4 | −11.9 (−33.0, 9.2) | 0.242 |
| ESR (mm/h) | 73.0 ± 36.4 | 74.2 ± 37.6 | −1.2 (−30.6, 28.1) | 0.932 |
| PCT (μg/L) | 0.08 ± 0.14 | 0.04 ± 0.02 | 0.04 (−0.04, 0.12) | 0.276 |
| CD4+ T (/ml) | 492.5 ± 158.4 | 421.0 ± 225.2 | 71.5 (−81.9, 224.9) | 0.346 |
| CD8+ T (/ml) | 243.3 ± 98.6 | 208.5 ± 109.1 | 34.7 (−47.6, 117.1) | 0.393 |
| CD3+ T (/ml) | 767.6 ± 212.1 | 649.9 ± 324.5 | 117.7 (−98.0, 333.4) | 0.272 |
| TGadmission (mmol/L) | 1.02 ± 0.39 | 1.08 ± 0.44 | −0.06 (−0.39, 0.26) | 0.698 |
| TGdischarge (mmol/L) | 1.62 ± 0.96 | 1.57 ± 0.61 | 0.05 (−0.60, 0.69) | 0.881 |
| cTNI (μg/L) | 0.096 ± 0.058 | 0.079 ± 0.072 | 0.017 (−0.07, 0.104) | 0.673 |
| proBNP (pg/ml) | 726.5 ± 407.6 | 544.7 ± 163.6 | 181.8 (−470.5, 834.1) | 0.506 |
RASI, the inhibitor of Renin–angiotensin system. Data are n (%) or mean ± SD.
*
Mean arterial pressure = (systolic pressure + 2 × diastolic pressure)/3.